Events
- Join Us at PEGS Boston 2024 | April 26, 2024
- Check Out Our CD40 mAb Phase II Poster at ASCO2024! | April 25, 2024
- Join us at Booth D23 at BIO KOREA 2024! May 8-10 | April 23, 2024
- Immuno-Oncology Summit Europe 2024: April 23-25 | April 11, 2024
- Festival of Biologics USA 2024: April 15-17 | April 11, 2024
- Webinar: Empowering Discovery and Development of Bispecific ADCs With a Common Light Chain Antibody Library and a Novel Linker/Payload | April 04, 2024
News
- April 2024 Newsletter | April 11, 2024
- Biocytogen’s Antibody Partner Syncromune® Inc. Presents Positive Results from SYNC-T™ SV-102 Phase 1 Trial at AACR Annual Meeting 2024 | April 09, 2024
- Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates | March 25, 2024
- Biocytogen Symposium 2024: New Targets, New Therapeutics | February 24, 2024
- Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement | February 20, 2024
- Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development | January 23, 2024
